TRDA
Entrada Therapeutics, Inc. · Healthcare
Director and 10% owner Kush Parmar bought $5.0M of Entrada Therapeutics, Inc.
Bought$5,000,000
$20.00Price
250,000Shares
+28%Stake
What TRDA did for a copier
- $1,000 copied at Fri, Nov 5 open, $25.33
- $541
- S&P 500, same days
- −2.7%
Measured over 30 trading days, to the Dec 20 close.
Kush Parmar's record
3 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Nov 2. Filed Fri, Nov 5, 8:49 AM ET, before the open. Returns use the Nov 5 open and the Dec 20 close. Not investment advice.